Harris L, L’Italien G, O’Connell T, Hasan Z, Hutchinson S, Lucas S. A framework for estimating the eligible patient population for new migraine acute therapies in the United States. Adv Ther. 2021;38(10):5087–97.

PubMed  PubMed Central  Article  Google Scholar 

Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies—successful translation from bench to clinic. Nat Rev Neurol. 2018;14(6):338–50.

CAS  PubMed  Article  Google Scholar 

Global regional. and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.

Article  Google Scholar 

Liu T, Gao YJ, Ji RR. Emerging role of toll-like receptors in the control of pain and itch. Neurosci Bull. 2012;28(2):131–44.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Pereira EA, Aziz TZ. Neuropathic pain and deep brain stimulation. Neurotherapeutics. 2014;11(3):496–507.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice ASC, et al. A new definition of neuropathic pain. Pain. 2011;152(10):2204–5.

PubMed  Article  Google Scholar 

Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7(4):281–9.

PubMed  Article  Google Scholar 

Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136(3):380–7.

PubMed  Article  Google Scholar 

Yang H, Wu L, Deng H, Chen Y, Zhou H, Liu M, et al. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia. J Neuroinflamm. 2020;17(1):154.

CAS  Article  Google Scholar 

Liu T, Berta T, Xu ZZ, Park CK, Zhang L, Lü N, et al. TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice. J Clin Invest. 2012;122(6):2195–207.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chen W, Lu Z. Upregulated TLR3 promotes neuropathic pain by regulating autophagy in rat with L5 spinal nerve ligation model. Neurochem Res. 2017;42(2):634–43.

CAS  PubMed  Article  Google Scholar 

Stokes JA, Cheung J, Eddinger K, Corr M, Yaksh TL. Toll-like receptor signaling adapter proteins govern spread of neuropathic pain and recovery following nerve injury in male mice. J Neuroinflamm. 2013;10:148.

Article  CAS  Google Scholar 

Li Y, Yin C, Li X, Liu B, Wang J, Zheng X, et al. Electroacupuncture alleviates paclitaxel-induced peripheral neuropathic pain in rats via suppressing TLR4 signaling and TRPV1 upregulation in sensory neurons. Int J Mol Sci. 2019;20(23):5917.

CAS  PubMed Central  Article  Google Scholar 

Xu ZZ, Kim YH, Bang S, Zhang Y, Berta T, Wang F, et al. Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade. Nat Med. 2015;21(11):1326–31.

CAS  PubMed  PubMed Central  Article  Google Scholar 

He L, Han G, Wu S, Du S, Zhang Y, Liu W, et al. Toll-like receptor 7 contributes to neuropathic pain by activating NF-κB in primary sensory neurons. Brain Behav Immun. 2020;87:840–51.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang ZJ, Guo JS, Li SS, Wu XB, Cao DL, Jiang BC, et al. TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG. J Exp Med. 2018;215(12):3019–37.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Luo X, Huh Y, Bang S, He Q, Zhang L, Matsuda M, et al. Macrophage toll-like receptor 9 contributes to chemotherapy-induced neuropathic pain in male mice. J Neurosci. 2019;39(35):6848–64.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lacagnina MJ, Watkins LR, Grace PM. Toll-like receptors and their role in persistent pain. Pharmacol Ther. 2018;184:145–58.

CAS  PubMed  Article  Google Scholar 

Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637–50.

CAS  PubMed  Article  Google Scholar 

Anderson KV, Bokla L, Nüsslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell. 1985;42(3):791–8.

CAS  PubMed  Article  Google Scholar 

Gay NJ, Keith FJ. Drosophila Toll and IL-1 receptor. Nature. 1991;351(6325):355–6.

CAS  PubMed  Article  Google Scholar 

Rosetto M, Engström Y, Baldari CT, Telford JL, Hultmark D. Signals from the IL-1 receptor homolog, Toll, can activate an immune response in a Drosophila hemocyte cell line. Biochem Biophys Res Commun. 1995;209(1):111–6.

CAS  PubMed  Article  Google Scholar 

Medzhitov R, Preston-Hurlburt P, Janeway CA.Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388(6640):394–7.

CAS  PubMed  Article  Google Scholar 

O’Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors—redefining innate immunity. Nat Rev Immunol. 2013;13(6):453–60.

PubMed  Article  CAS  Google Scholar 

Fore F, Indriputri C, Mamutse J, Nugraha J. TLR10 and its unique anti-inflammatory properties and potential use as a target in therapeutics. Immune Netw. 2020;20(3):e21.

PubMed  PubMed Central  Article  Google Scholar 

Lim KH, Staudt LM. Toll-like receptor signaling. Cold Spring Harb Perspect Biol. 2013;5(1):a011247.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity. 2010;32(3):305–15.

CAS  PubMed  Article  Google Scholar 

McGettrick AF, O’Neill LA. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol. 2010;22(1):20–7.

CAS  PubMed  Article  Google Scholar 

Okun E, Griffioen KJ, Son TG, Lee JH, Roberts NJ, Mughal MR, et al. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J Neurochem. 2010;114(2):462–74.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lathia JD, Okun E, Tang SC, Griffioen K, Cheng A, Mughal MR, et al. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J Neurosci. 2008;28(51):13978–84.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 2007;9(9):1081–8.

CAS  PubMed  Article  Google Scholar 

Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A. 2010;107(25):11555–60.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhu JW, Li YF, Wang ZT, Jia WQ, Xu RX. Toll-like receptor 4 deficiency impairs motor coordination. Front Neurosci. 2016;10:33.

PubMed  PubMed Central  Google Scholar 

Anthoney N, Foldi I, Hidalgo A. Toll and Toll-like receptor signalling in development. Development. 2018;145(9):dev156018.

PubMed  Article  CAS  Google Scholar 

Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3–9.

CAS  PubMed  Article  Google Scholar 

Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373–84.

CAS  PubMed  Article  Google Scholar 

Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol. 2012;4(11):a011254.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Jiang S, Li X, Hess NJ, Guan Y, Tapping RI. TLR10 is a negative regulator of both MyD88-dependent and -independent TLR signaling. J Immunol. 2016;196(9):3834–41.

CAS  PubMed  Article  Google Scholar